4//SEC Filing
Avnur Zafrira 4
Accession 0001415889-21-002613
CIK 0001035354other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:10 PM ET
Size
5.8 KB
Accession
0001415889-21-002613
Insider Transaction Report
Form 4
Avnur Zafrira
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-19+20,000→ 20,000 totalExercise: $1.48Exp: 2031-05-19→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock option was issued pursuant to the Issuer's 2018 Equity Incentive Plan and vests as follows: one half (1/2) of the shares underlying the option shall vest on May 19, 2022 (the "Cliff Vesting Date"), the remainder of the grant shall vest in twelve (12) equal installments on each successive monthly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001726049
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:10 PM ET
- Size
- 5.8 KB